LUNG SQUAMOUS CELL CARCINOMA
Clinical trials for LUNG SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancer? JMT106 injection enters first human trial
Disease control Recruiting nowThis early-stage trial tests a new drug called JMT106 in 200 people with advanced solid tumors, including lung and liver cancers, who have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug shows any sign of shrinkin…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New drug targets Hard-to-Treat cancers with genetic weakness
Disease control Recruiting nowThis study tests a new drug, TER-2013, in people with advanced solid tumors (like breast, ovarian, or lung cancer) that have specific genetic changes in the AKT/PI3K/PTEN pathway. The goal is to see if the drug is safe and can shrink tumors. About 205 participants will receive th…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Terremoto Biosciences Inc. • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New hope for advanced cancers: experimental drug AZD5335 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called AZD5335, alone or with other cancer medicines, in people with advanced ovarian, lung, or endometrial cancers that have not responded to standard treatments. The main goals are to check the drug's safety and find the right dose. About 5…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
Radiation boosts immunotherapy in lung cancer trial
Disease control Recruiting nowThis phase 2 trial tests whether adding low-dose radiation to standard immunotherapy (sintilimab) and chemotherapy can shrink tumors better than immunotherapy and chemo alone in people with advanced squamous cell lung cancer. About 114 participants will be randomly assigned to on…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC